BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38167452)

  • 1. A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.
    Feng C; Yu A; Wang Z; Wang K; Chen J; Wu Y; Deng T; Chen H; Hou Y; Ma S; Dai X; Huang L
    J Exp Clin Cancer Res; 2024 Jan; 43(1):9. PubMed ID: 38167452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium thiosulfate inhibits epithelial-mesenchymal transition in melanoma via regulating the Wnt/β-catenin signaling pathway.
    Wang D; Li S; Chen Y; Luo J; Li L; Wang B; Xu Y; Liang Y
    J Dermatol Sci; 2023 Feb; 109(2):89-98. PubMed ID: 36870927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin regulates mammary stem cell function and tumorigenesis by potentiating Wnt/β-catenin signaling.
    Bresson L; Faraldo MM; Di-Cicco A; Quintanilla M; Glukhova MA; Deugnier MA
    Development; 2018 Feb; 145(4):. PubMed ID: 29361573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF3 Transcription Activates WNT1 and Promotes the Growth and Metastasis of Gastric Cancer via Activation of the WNT/β-Catenin Signaling Pathway.
    Li Y; Wang Y; Zou Q; Li S; Zhang F
    Lab Invest; 2023 Jun; 103(6):100078. PubMed ID: 36827869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/β-catenin pathway.
    Wang E; Wang D; Li B; Ma H; Wang C; Guan L; Zhang H; Yi L; Li S
    Oncol Rep; 2017 Jan; 37(1):379-387. PubMed ID: 27878263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
    Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway].
    Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNA-CASC15 Promotes Cell Proliferation, Migration, and Invasion by Activating Wnt/β-Catenin Signaling Pathway in Melanoma.
    Sheng L; Wei R
    Pathobiology; 2020; 87(1):20-29. PubMed ID: 31838468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
    Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
    Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway.
    Fang Q; Que T; Liu B; Dan W; Wei Y; Ren B; Fan Y; Hou T; Zeng J
    Front Biosci (Landmark Ed); 2022 Dec; 27(12):335. PubMed ID: 36624947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBBP4 promotes colon cancer malignant progression
    Li YD; Lv Z; Zhu WF
    World J Gastroenterol; 2020 Sep; 26(35):5328-5342. PubMed ID: 32994691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GBP2 Is a Favorable Prognostic Marker of Skin Cutaneous Melanoma and Affects Its Progression via the Wnt/β-catenin Pathway.
    Ji G; Luo B; Chen L; Shen G; Tian T
    Ann Clin Lab Sci; 2021 Nov; 51(6):772-782. PubMed ID: 34921030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
    Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
    Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling.
    Zhang L; Chen J; Chen Y; Zou D; Pu Y; Wei M; Huang Y; Li Y; Huang Q; Chen J
    Anticancer Agents Med Chem; 2023; 23(1):94-104. PubMed ID: 35598249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.